ciglitazone has been researched along with Hyperglycemia, Postprandial in 7 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
Hyperglycemia, Postprandial: Abnormally high BLOOD GLUCOSE level after a meal.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clark, DA | 1 |
Goldstein, SW | 1 |
Volkmann, RA | 1 |
Eggler, JF | 1 |
Holland, GF | 1 |
Hulin, B | 1 |
Stevenson, RW | 1 |
Kreutter, DK | 1 |
Gibbs, EM | 1 |
Krupp, MN | 1 |
Wrobel, J | 1 |
Li, Z | 1 |
Dietrich, A | 1 |
McCaleb, M | 1 |
Mihan, B | 1 |
Sredy, J | 1 |
Sullivan, D | 1 |
Fujisawa, K | 1 |
Nishikawa, T | 1 |
Kukidome, D | 1 |
Imoto, K | 1 |
Yamashiro, T | 1 |
Motoshima, H | 1 |
Matsumura, T | 1 |
Araki, E | 1 |
Mishra, PK | 1 |
Tyagi, N | 1 |
Sen, U | 1 |
Joshua, IG | 1 |
Tyagi, SC | 1 |
Yen, TT | 1 |
Gill, AM | 1 |
Powell, JG | 1 |
Sampson, BM | 1 |
Chang, AY | 1 |
Wyse, BM | 2 |
Diani, AR | 1 |
Sawada, GA | 1 |
7 other studies available for ciglitazone and Hyperglycemia, Postprandial
Article | Year |
---|---|
Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents.
Topics: Adipose Tissue; Animals; Benzofurans; Biological Transport, Active; Cell Line; Deoxyglucose; Hypergl | 1991 |
Novel 5-(3-aryl-2-propynyl)-5-(arylsulfonyl)thiazolidine-2,4-diones as antihyperglycemic agents.
Topics: Animals; Blood Glucose; Hyperglycemia; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Rats; Ra | 1998 |
TZDs reduce mitochondrial ROS production and enhance mitochondrial biogenesis.
Topics: Cells, Cultured; DNA, Mitochondrial; Heat-Shock Proteins; Humans; Hyperglycemia; Hypoglycemic Agents | 2009 |
Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol.
Topics: Animals; Antioxidants; Cardiomyopathies; Cyclic N-Oxides; Diabetes Complications; Diabetes Mellitus, | 2010 |
Ciglitazone prevents and reverses dexamethasone-induced hyperglycemia in female viable yellow mice.
Topics: Administration, Oral; Animals; Blood Glucose; Body Weight; Corticosterone; Dexamethasone; Dose-Respo | 1992 |
The hypoglycemic effect of ciglitazone in obese, hyperglycemic animal models.
Topics: Adipose Tissue; Adipose Tissue, Brown; Animals; Blood Glucose; Disease Models, Animal; Glycolysis; H | 1988 |
A review of the effects of ciglitazone on the pancreatic islets of obese, hyperglycemic mice.
Topics: Animals; Hyperglycemia; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Mice; Mice, Obese; | 1988 |